Highlights
• This ESMO Guideline provides key recommendations on the role of PROMs during the care of patients with cancer.
• It covers the use of PROMs in patients with cancer from the start of active treatment during follow-up and at the end of life.
• Recommendations are based on available scientific evidence and the authors’ collective expert consensus.
• Authorship includes a multidisciplinary group of experts from Europe, North America, Asia & Australia.